ABT logo

ABTAbbott Laboratories

$89.46
$0.29
(0.33%)
Today
Updated: 11:58 AM EDT
EarningsJul 16
Mkt Cap$155.32B
Vol2.58M
News
all
press releases
Abbott (ABT) Dips More Than Broader Market: What You Should Know
In the most recent trading session, Abbott (ABT) closed at $89.17, indicating a -2.28% shift from the previous trading day.
Zacks
News Placeholder
More News
News Placeholder
Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story
ABT's Exact Sciences acquisition expands its cancer diagnostics portfolio as new data and screening guidelines strengthen growth prospects.
Zacks
News Placeholder
Is Medtronic Stock a Buy at 14x Forward Earnings?
MDT trades at about 14x forward earnings with a 3.5% yield as fiscal 2027 guidance points to steady growth, but margins face tariffs and mix pressure.
Zacks
News Placeholder
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks
News Placeholder
Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock
Goldman Sachs Maintains Buy Rating on Abbott Laboratories?(ABT) Stock...
Yahoo! Finance: News
News Placeholder
New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers
New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health...
PR Newswire
News Placeholder
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis PR Newswire ABBOTT PARK, Ill., June 6, 2026 Diabetic ketoacidosis (DKA) can develop quickly and is...
PR Newswire
News Placeholder
Abbott Addresses a Major Diabetes Care Gap With Tech Innovation
ABT wins the CE Mark for Libre Duo sensors that track glucose and ketones every minute, aiming to spot DKA risks earlier and reduce routine testing.
Zacks
News Placeholder
QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk
QDEL's Q1 results show how a milder respiratory season can pressure revenue, margins and cash flow despite stable testing market share.
Zacks
News Placeholder
Why Investors Are Cautious on Abbott Laboratories (ABT)
Why Investors Are Cautious on Abbott Laboratories (ABT...
Yahoo! Finance: News
<
1
2
...
>

Advertisement|Remove ads.